Browsing Tag
chronic graft-versus-host disease
2 posts
Sanofi’s second chance: Why Europe is warming up to Rezurock after initial CHMP rejection
Sanofi’s Rezurock secures EU conditional approval recommendation for chronic GVHD. Find out what changed and how this could reshape rare disease care.
Niktimvo FDA approval brings new hope for chronic graft-versus-host disease patients
The U.S. Food and Drug Administration (FDA) has approved Niktimvo (axatilimab-csfr), an anti-CSF-1R antibody, for treating chronic graft-versus-host…